Literature DB >> 22481618

The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.

Yuko Takeba1, Naoki Matsumoto, Minoru Watanabe, Sachiko Takenoshita-Nakaya, Yuki Ohta, Toshio Kumai, Masayuki Takagi, Satoshi Koizumi, Takeshi Asakura, Takehito Otsubo.   

Abstract

PURPOSE: Rho kinase is an important factor in tumor progression. We demonstrated that Rho kinase-associated coil-containing protein kinase (ROCK) is expressed in hepatic tissues in hepatocellular carcinoma (HCC) and confirmed its roles in cell survival in HCC cells using the ROCK inhibitor, fasudil.
METHODS: ROCK protein levels were estimated in hepatic tissues with HCC compared with healthy liver tissues or hepatic hemangioma tissues using immunohistochemistry. Furthermore, HepG2 and Huh7 cells were cultured with ROCK inhibitor, fasudil for 24 h in vitro. Cell proliferation was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt assay, and apoptotic cells were detected by cell death ELISA. The expression apoptosis-related proteins were analyzed using Western blotting.
RESULTS: Fasudil significantly decreased cell proliferation and induced apoptosis mediated by increases in p53, Bax, caspase-9, and caspase-3 in HepG2 and Huh7 cells. The induction of apoptosis was inhibited in HCC cells precultured with p53 decoy oligodeoxynucleotide.
CONCLUSION: These results suggest that ROCK inhibits the p53-mediated apoptosis pathway in HCC. Fasudil may thus be a beneficial approach to HCC therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22481618     DOI: 10.1007/s00280-012-1862-6

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  9 in total

1.  Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.

Authors:  Mingliang He; Ming Luo; Qingyu Liu; Jingkao Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Leping Ouyang; Anmin Liu
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

2.  Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.

Authors:  Vittorio Di Maso; María Gabriela Mediavilla; Carlo Vascotto; Francesco Lupo; Umberto Baccarani; Claudio Avellini; Gianluca Tell; Claudio Tiribelli; Lory Saveria Crocè
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

3.  Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.

Authors:  Adrienn Sipos; Judit Iván; Bálint Bécsi; Zsuzsanna Darula; István Tamás; Dániel Horváth; Katalin F Medzihradszky; Ferenc Erdődi; Beáta Lontay
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

Review 4.  Novel Insights into the Roles of Rho Kinase in Cancer.

Authors:  Lei Wei; Michelle Surma; Stephanie Shi; Nathan Lambert-Cheatham; Jianjian Shi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-01-02       Impact factor: 4.291

5.  Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.

Authors:  Xiaowen Zhang; Nan Wu
Journal:  Drug Des Devel Ther       Date:  2018-02-23       Impact factor: 4.162

6.  Antitumor effects of dioscin in A431 cells via adjusting ATM/p53-mediated cell apoptosis, DNA damage and migration.

Authors:  Peng Wang; Chun Wang; Chunying Liu
Journal:  Oncol Lett       Date:  2020-11-19       Impact factor: 2.967

7.  Autophagy Inhibition Stimulates Apoptosis in Oesophageal Squamous Cell Carcinoma Treated with Fasudil.

Authors:  Fa-Jun Xie; Qiu-Qing Zheng; Jing Qin; Ling-Ling Zhang; Na Han; Wei-Min Mao
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

8.  Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.

Authors:  Ying Zhao; Yu Zhang; Milad Vazirinejad Mehdiabad; Ke Zhou; Yuyuan Chen; Lei Li; Jun Guo; Chuanrui Xu
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

9.  Inhibition of Rho-Kinase Downregulates Th17 Cells and Ameliorates Hepatic Fibrosis by Schistosoma japonicum Infection.

Authors:  Wei Zhou; Yingying Yang; Congjin Mei; Panpan Dong; Shasha Mu; Hongchu Wu; Yonghua Zhou; Yi Zheng; Fukun Guo; Jun-Qi Yang
Journal:  Cells       Date:  2019-10-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.